相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 英文名:
SKF-92334
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
51481-61-9
- 规格:
10 mM * 1 mL/100 mg/1 g/5 g/10 g
| 规格: | 10 mM * 1 mL | 产品价格: | ¥550.0 |
|---|---|---|---|
| 规格: | 100 mg | 产品价格: | ¥350.0 |
| 规格: | 1 g | 产品价格: | ¥500.0 |
| 规格: | 5 g | 产品价格: | ¥840.0 |
| 规格: | 10 g | 产品价格: | ¥1050.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
Cimetidine
CAS No. : 51481-61-9
MCE 国际站:Cimetidine
产品活性:Cimetidine (SKF-92334) 是一种具有口服活性的,可逆的组胺 H2 受体拮抗剂,Ki 为 0.6 μM。Cimetidine 是一种胃酸减少剂,可用于十二指肠和胃溃疡研究。Cimetidine 具有抗癌和抗炎活性。
研究领域:GPCR/G Protein | Neuronal Signaling | Immunology/Inflammation | Anti-infection
作用靶点:Histamine Receptor | Bacterial
In Vitro: Cimetidine (SKF-92334), a partial agonist for H2R, has a pharmacological profile different from ranitidine and famotidine, possibly contributing to its antitumor activity on gastrointestinal cancers [1]. Cimetidine had no effect on the uptake and cytotoxicity of cisplatin in ovarian cancer cells with high OCT2 mRNA levels (IGROV-1 cells).
Cimetidine showed no effect on proliferation, survival, migration and invasion of 3LL cells. Cimetidine reversed MDSC-mediated T-cell suppression, and improved IFN-γ production.
Cimetidine-mediated down-regulation of NCAM involved suppression of the nuclear translocation of NF-kappaB, a transcriptional activator of NCAM gene expression.
In Vivo: Cimetidine (SKF-92334) reduceS CD11b(+)Gr-1(+) myeloid derived-suppressive cell (MDSC) accumulation in spleen, blood and tumor tissue of tumor-bearing mice.
Cimetidine exerts a beneficial effect on periodontal disease in rats, decreasing the RANKL/OPG ratio in gingival connective tissue and reducing alveolar bone resorption.
相关产品:Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | Anti-Infection Compound Library | GPCR/G Protein Compound Library | Immunology/Inflammation Compound Library | Neuronal Signaling Compound Library | FDA-Approved Drug Library | Anti-Cancer Compound Library | Antiviral Compound Library | CNS-Penetrant Compound Library | Drug Repurposing Compound Library | Endocrinology Compound Library | Antibacterial Compound Library | NMPA-Approved Drug Library | Orally Active Compound Library | Neurotransmitter Receptor Compound Library | FDA Approved & Pharmacopeial Drug Library | Drug-Induced Liver Injury (DILI) Compound Library | Rare Diseases Drug Library | FDA-Approved Anticancer Drug Library | Human Metabolite Library | Coagulation and Anti-coagulation Compound Library | Off-patent Drug Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Rapamycin | Doxorubicin hydrochloride | Bafilomycin A1 | Dexamethasone | Puromycin dihydrochloride | Dimethyl sulfoxide | Staurosporine | Actinomycin D | G-418 disulfate | Etoposide | 5-Azacytidine | Nigericin sodium salt | Brefeldin A | Estradiol | CCCP | Ionomycin | Resveratrol | Hygromycin B | Tunicamycin | Mitomycin C | Everolimus | Doxycycline hyclate | Tacrolimus | Methotrexate | Neomycin sulfate | Acetaminophen | Streptozotocin | Anisomycin | Cholesterol
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验20世纪80年代初,西咪替丁(Cimetidine)也用于免疫增强,西眯替了通过与Ts细胞的H2受体结合,可以阻止组胺对丁s细胞的活化作用,从而增强机体的免疫功能。
2.西咪替丁(cimetidine) 是一种组胺拮抗剂,可与组胺2(HZ)受体结合,竞争性地抑制组胺的作用,临床主要用于 胃及十二指肠溃疡 治疗。80年代初,由于发现TS细胞表面具有H2受体;组胺与TS细胞的H2受体结合后,可使TS细胞活化而抑制机体的免疫功能。西咪替丁通过与TS细胞的H2受体结合,可以阻止组胺对TS细胞的活化作用,从而增强机体的免疫功能。研究表明,西咪替丁可以增强正常或免疫缺损小鼠的免疫功能,并能明显抑制肿瘤的生长。 左旋
治 疗 前 治 疗 后 伴胃炎数 活动性炎 炎症减轻(%) 活动性炎消失(%) CBS 60 29 55/60(92) 29/29(100) 西咪替丁 52 25 32/52(61) 15/25(60) 雷尼替丁 50 22 30/50(60) 11/22(50) 3 讨论 清除Hp感染已成为治疗 慢性胃炎 及消化性溃疡的重要措施。本组观察结果证明CBS对Hp清除率为95%,西咪替丁为23%,雷尼替丁为22%
技术资料暂无技术资料 索取技术资料

















